Stocks News

LAST PRICE
276.7300
TODAY'S CHANGE (%)
Trending Up3.5400 (1.2958%)

Bid / Lots
276.4000/ 1
Ask / Lots
299.9400/ 1
Open / Previous Close
274.0500 / 273.1900
Day Range
Low 272.1500
High 279.4800
52 Week Range
Low 208.6249
High 280.0000
Volume
410,381
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 10 hours ago by Business Wire
  10 hours ago by Business Wire
  Companies Mentioned: UTHR
  United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company's operations during a fireside chat session at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida.
- United Therapeutics Corporation to Present at the Goldman Sachs 45(th) Annual Global Healthcare Conference, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: UTHR
  SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--June 05, 2024--
  United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company's operations during a fireside chat session at the Goldman Sachs 45(th) Annual Global Healthcare Conference in Miami Beach, Florida.
Jun 3, 2024
- Liquidia's Yutrepia Launch Cleared as Court Denies Injunction, from 8:41AM ET on Monday Jun 03, 2024 by MT Newswires
  8:41AM ET on Monday Jun 03, 2024 by MT Newswires
  Companies Mentioned: UTHR, LQDA
  08:41 AM EDT, 06/03/2024 (MT Newswires) -- Liquidia (LQDA) said Monday that the US District Court for the District of Delaware rejected a motion by United Therapeutics (UTHR) to block the launch of its inhalation powder, Yutrepia to treat pulmonary ...
- *DJ Liquidia District Court Issues Favorable Ruling and Denies United Therapeutics' Request to Block Yutrepia Launch >LQDA, from 7:03AM ET on Monday Jun 03, 2024 by Dow Jones
  7:03AM ET on Monday Jun 03, 2024 by Dow Jones
  Companies Mentioned: UTHR, LQDA
May 21, 2024
- DJ United Therapeutics Is Maintained at Overweight by JP Morgan, from 12:23PM ET on Tuesday May 21, 2024 by Dow Jones
  12:23PM ET on Tuesday May 21, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 21, 2024 12:23 ET (16:23 GMT)

May 31, 2024
- Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing, from 3:49AM ET on Friday May 31, 2024 by MT Newswires
  3:49AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: NBIX
- BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing, from 3:38AM ET on Friday May 31, 2024 by MT Newswires
  3:38AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: BMRN
May 29, 2024
- Medpace Holdings Insider Sold Shares Worth $3,828,058, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 29, 2024 by MT Newswires
  4:28PM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: MEDP
- TD Cowen Starts Medpace Holdings With Buy Rating, $452 Price Target, from 7:45AM ET on Wednesday May 29, 2024 by MT Newswires
  7:45AM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 28, 2024
- Neurocrine Biosciences Says CEO Kevin Gorman Retiring, from 5:09PM ET on Tuesday May 28, 2024 by MT Newswires
  5:09PM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: NBIX
- BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments, from 9:29AM ET on Tuesday May 28, 2024 by MT Newswires
  9:29AM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: BCTX, BGNE
- UBS Raises Price Target on Neurocrine Biosciences to $193 From $174, Maintains Buy Rating, from 9:20AM ET on Tuesday May 28, 2024 by MT Newswires
  9:20AM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: NBIX
- Mizuho Starts Medpace Holdings With Buy Rating, $435 Price Target, from 8:01AM ET on Tuesday May 28, 2024 by MT Newswires
  8:01AM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 24, 2024
- BeiGene Says Studies Highlight Effectiveness, Safety of Lymphoma Drug Brukinsa, from 8:36AM ET on Friday May 24, 2024 by MT Newswires
  8:36AM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: BGNE
May 22, 2024
- Medpace Holdings Insider Sold Shares Worth $1,608,764, According to a Recent SEC Filing, from 4:29PM ET on Wednesday May 22, 2024 by MT Newswires
  4:29PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: MEDP

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

Today

United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 10 hours ago by Business Wire

United Therapeutics Corporation to Present at the Goldman Sachs 45(th) Annual Global Healthcare Conference, from 10 hours ago by Dow Jones

Jun 3, 2024

Liquidia's Yutrepia Launch Cleared as Court Denies Injunction, from 8:41AM ET on Monday Jun 03, 2024 by MT Newswires

*DJ Liquidia District Court Issues Favorable Ruling and Denies United Therapeutics' Request to Block Yutrepia Launch >LQDA, from 7:03AM ET on Monday Jun 03, 2024 by Dow Jones

May 21, 2024

DJ United Therapeutics Is Maintained at Overweight by JP Morgan, from 12:23PM ET on Tuesday May 21, 2024 by Dow Jones

Peers Headlines

May 31, 2024

Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing, from 3:49AM ET on Friday May 31, 2024 by MT Newswires

BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing, from 3:38AM ET on Friday May 31, 2024 by MT Newswires

May 29, 2024

Medpace Holdings Insider Sold Shares Worth $3,828,058, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 29, 2024 by MT Newswires

TD Cowen Starts Medpace Holdings With Buy Rating, $452 Price Target, from 7:45AM ET on Wednesday May 29, 2024 by MT Newswires

May 28, 2024

Neurocrine Biosciences Says CEO Kevin Gorman Retiring, from 5:09PM ET on Tuesday May 28, 2024 by MT Newswires

BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments, from 9:29AM ET on Tuesday May 28, 2024 by MT Newswires

UBS Raises Price Target on Neurocrine Biosciences to $193 From $174, Maintains Buy Rating, from 9:20AM ET on Tuesday May 28, 2024 by MT Newswires

Mizuho Starts Medpace Holdings With Buy Rating, $435 Price Target, from 8:01AM ET on Tuesday May 28, 2024 by MT Newswires

May 24, 2024

BeiGene Says Studies Highlight Effectiveness, Safety of Lymphoma Drug Brukinsa, from 8:36AM ET on Friday May 24, 2024 by MT Newswires

May 22, 2024

Medpace Holdings Insider Sold Shares Worth $1,608,764, According to a Recent SEC Filing, from 4:29PM ET on Wednesday May 22, 2024 by MT Newswires